Patient Guide: A Study to Optimize Subretinal Surgical Delivery and to Evaluate Safety and Activity of Opregen in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (GAlette); Adaptive Optics (AO) Retinal Imaging Substudy in Association With Study GR44251

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 13 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05626114
Status: 🟢 Enrolling Now
Condition: Geographic Atrophy
Phase: PHASE2

Where You Can Participate

This study is available at 13 locations across the country.

Top locations include:
  • • Beverly Hills, California
  • • Sacramento, California
  • • San Francisco, California
  • • And 10 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to Optimize Subretinal Surgical Delivery and to Evaluate Safety and Activity of Opregen in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (GAlette); Adaptive Optics (AO) Retinal Imaging Substudy in Association With Study GR44251 - Join Clinical Trial NCTNCT05626114

How to Join This Clinical Trial - NCTNCT05626114

Learn how to participate in this PHASE2 trial studying an investigational therapy for Geographic Atrophy. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Geographic Atrophy. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Geographic Atrophy
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT05626114 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 13 locations. Find a study site near you:

Clinical Research Site

Beverly Hills, California 90211 - United States

Status: RECRUITING

Clinical Research Site

Sacramento, California 95825 - United States

Status: RECRUITING

Clinical Research Site

San Francisco, California 94109-5520 - United States

Status: RECRUITING

Clinical Research Site

Baltimore, Maryland 21209-2219 - United States

Status: RECRUITING

Clinical Research Site

St Louis, Missouri 63128-1729 - United States

Status: RECRUITING

Clinical Research Site

Blue Ash, Ohio 45242-5537 - United States

Status: RECRUITING

Clinical Research Site

Philadelphia, Pennsylvania 19107-5109 - United States

Status: RECRUITING

Clinical Research Site

Nashville, Tennessee 37203-1513 - United States

Status: RECRUITING

Clinical Research Site

Austin, Texas 78750-2298 - United States

Status: RECRUITING

Clinical Research Site

Lynchburg, Virginia 24502-4271 - United States

Status: RECRUITING

And 3 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Geographic Atrophy:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships